Idiopathic thrombocytopaenic purpura in patients during remission of Hodgkin's disease
Tahiliani, R.R.; Banavali, S.D.; Parikh, P.M.; Charak, B.S.; Nair, C.N.; Saikia, T.K.; Gopal, R.; Advani, S.H.
Journal of the Association of Physicians of India 37(2): 141-143
1989
ISSN/ISBN: 0004-5772 PMID: 2808278 Document Number: 340867
Four patients with Hodgkin's disease developed thrombocytopaenic purpura during remission phase. The interval at which it occurred following chemotherapy ranged from a period of 4 months to 4 years. Detailed investigations failed to reveal recurrence of Hodgkin's disease. All patients responded well to steroid therapy. In the median duration of one year follow-up Hodgkin's disease remained under control. Thus, the occurrence of thombocytopaenic purpura in patients treated for Hodgkin's lymphoma need not imply recurrence or active Hodgkin's disease.